HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
T Gamucci Selected Research
T Gamucci Research Topics
Disease
13
Breast Neoplasms (Breast Cancer)
04/2021 - 02/2000
10
Neoplasms (Cancer)
07/2021 - 02/2000
3
Disease Progression
07/2021 - 02/2000
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2004 - 07/2000
2
Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 03/2016
2
Diarrhea
02/2014 - 09/2003
2
Colorectal Neoplasms (Colorectal Cancer)
06/2005 - 09/2003
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2016
1
Cancer Pain
01/2016
1
Pain (Aches)
01/2016
1
Drug-Related Side Effects and Adverse Reactions
01/2016
1
Febrile Neutropenia
01/2014
1
Dysgerminoma
05/2011
1
Neoplasm Metastasis (Metastasis)
11/2003
1
Neutropenia
07/2002
1
Leiomyosarcoma
03/2001
1
Sarcoma (Soft Tissue Sarcoma)
03/2001
Drug/Important Bio-Agent (IBA)
7
Paclitaxel (Taxol)
FDA Link
Generic
04/2021 - 02/2000
4
Capecitabine (Xeloda)
FDA Link
02/2014 - 09/2003
4
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2004 - 02/2000
3
Bevacizumab (Avastin)
FDA Link
04/2021 - 04/2013
2
eribulin
FDA Link
04/2021 - 01/2021
2
Platinum
IBA
03/2016 - 05/2011
2
Lapatinib (GW572016)
FDA Link
02/2014 - 06/2012
2
ErbB Receptors (EGF Receptor)
IBA
02/2014 - 06/2012
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2014 - 03/2001
2
Docetaxel (Taxotere)
FDA Link
04/2013 - 10/2007
2
Epirubicin (Ellence)
FDA Link
Generic
10/2007 - 03/2001
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
06/2005 - 09/2003
2
Anthracyclines
IBA
11/2003 - 07/2002
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2003 - 07/2002
2
Cytotoxins (Cytolysins)
IBA
11/2003 - 02/2003
1
RNA (Ribonucleic Acid)
IBA
07/2021
1
Biological Products
IBA
07/2021
1
Biomarkers (Surrogate Marker)
IBA
07/2021
1
MicroRNAs (MicroRNA)
IBA
07/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021
1
Cancer Vaccines
IBA
10/2019
1
Immune Checkpoint Inhibitors
IBA
10/2019
1
Epidermal Growth Factor (EGF)
IBA
10/2019
1
Vaccines
IBA
10/2016
1
Everolimus
FDA Link
10/2016
1
exemestane (Aromasin)
FDA Link
10/2016
1
Trabectedin
IBA
03/2016
1
Opioid Analgesics (Opioids)
IBA
01/2016
1
Analgesics (Analgesic Drugs)
IBA
01/2016
1
Buprenorphine (Subutex)
FDA Link
Generic
01/2016
1
Fentanyl (Sublimaze)
FDA Link
Generic
01/2016
1
Morphine (MS Contin)
FDA Link
Generic
01/2016
1
Oxycodone (Oxycontin)
FDA Link
Generic
01/2016
1
Biological Factors
IBA
05/2013
1
Trastuzumab (Herceptin)
FDA Link
06/2012
1
Leucovorin (Folinic Acid)
FDA Link
06/2005
1
Fluorouracil (Carac)
FDA Link
Generic
06/2005
1
Carboplatin (JM8)
FDA Link
Generic
03/2004
1
thiamine triphosphorate (TTP)
IBA
11/2003
1
taxane
IBA
11/2003
1
Antineoplastic Agents (Antineoplastics)
IBA
09/2003
1
Type I DNA Topoisomerases (Topoisomerase I)
IBA
02/2003
1
DNA (Deoxyribonucleic Acid)
IBA
02/2003
1
acridine DACA
IBA
02/2003
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2001
1
Ifosfamide
FDA Link
Generic
03/2001
1
lurtotecan
IBA
07/2000
1
Pharmaceutical Preparations
IBA
02/2000
Therapy/Procedure
10
Drug Therapy (Chemotherapy)
01/2021 - 02/2000
6
Therapeutics
04/2021 - 02/2000
2
Immunotherapy
10/2019 - 10/2016
1
Induction Chemotherapy
04/2013
1
Retreatment
06/2012
1
Drug Tapering
09/2003